MDV-3100 - Key patent, SPC, and data exclusivity expiry (44 country coverage)
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selector report covers MDV-3100 MDV-3100 indications: Treatment of prostate cancer MDV-3100 innovator: Medivation (MDV-3100); Astellas Pharma (MDV-3100) Examples of information found in this online report include : Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term extensions in other countries Data exclusivity calculated on a country by country basis Summary of dosage forms, strengths, indications and active ingredient forms of the brand product DMF & Paragraph IV filings Litigation alerts Marketing authorisation holders in selected territories Patent risk analysis via graphical display of da...